Peter Olagunju, Chief Technology Officer, TCR2 Therapeutics

HLTH @HLTH

Peter Olagunju is the Chief Technology Officer for TCR2, a clinical-stage cell therapy company with a pipeline of novel T cell therapies for cancer pa

Limited edition

$500

Editions left

1 of 1
Buy now
  • Contract Address 0x9603...b382
  • Token Standard ERC-1155
  • Network Ethereum